Kalincik, T. Et Al. 2016. Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a. ECTRIMS 2016 .

Kalincik, T., Brown, j., Robertson, R., Willis, m., Scolding, N., Pearson, O., ... Ziemsen, T.(2016). Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a . ECTRIMS 2016

Kalincik, Tomas Et Al. "Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a," ECTRIMS 2016, 2016

Kalincik, Tomas Et Al. "Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a." ECTRIMS 2016 , 2016

Kalincik, T. Et Al. (2016) . "Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a." ECTRIMS 2016 .

@conferencepaper{conferencepaper, author={Tomas Kalincik Et Al. }, title={Comparison of 5 year treatment outcomes between alemtuzumab versus natalizumab fingolimod and interferon 1a}, congress name={ECTRIMS 2016}, city={}, country={}, year={2016}}